For a HealthHombre service announcement, please click here.

Search Sector

Mine Hombre's database of thousands of key sites for powerful, focused searches of the money/medicine space.

Special Searches

     A/B MACs

     DME MACs

     Private Insurers

Archives

AHRQ Extends Period for Commenting on Assessment of Off-Label Indications for Certain Cancer Drugs . . .

publication date: Oct 30, 2009
Download Print
Previous | Next
 

Currently Available for Review

Technology Assessment: Report on the Evidence Regarding Off-Label Indications for Targeted Therapies used in Cancer Treatment (PDF file, 4.2 MB; PDF Help)
Date Available: 9:00 AM October 26 - 5:00 PM November 16.

Note: Due to a delay in the distribution of the review announcement to the TA Program E-mail list, the review period for the technology assessment draft on targeted therapies for cancer will be extended until November 16, 2009.


Word on the Street

The Wall Street Journal says HealthHombre "reads more regulations, proposed rules, draft legislation and other stuff than is healthy for any person."